{"symbol": "PHIO", "companyName": "RXi Pharmaceuticals", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.rxipharma.com", "description": "RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.", "CEO": "Geert Cauwenbergh", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}